In addition, co-treatment with TRAIL and a cFLIP-targeting siRNA has been recently reported to enhance the apoptosis of TRAIL-resistant tumor cells via caspase-8 activation [35, 36]. This evidence concerns the gene CASP8 and neoplasm.